These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29469596)

  • 1. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets.
    Mienda BS; Salihu R; Adamu A; Idris S
    Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics and the post-genome revolution.
    Amini S; Tavazoie S
    Curr Opin Microbiol; 2011 Oct; 14(5):513-8. PubMed ID: 21816663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates.
    Butt AM; Nasrullah I; Tahir S; Tong Y
    PLoS One; 2012; 7(8):e43080. PubMed ID: 22912793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From microbial gene essentiality to novel antimicrobial drug targets.
    Mobegi FM; van Hijum SA; Burghout P; Bootsma HJ; de Vries SP; van der Gaast-de Jongh CE; Simonetti E; Langereis JD; Hermans PW; de Jonge MI; Zomer A
    BMC Genomics; 2014 Nov; 15(1):958. PubMed ID: 25373505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapping into Salmonella typhimurium LT2 genome in a quest to explore its therapeutic arsenal: A metabolic network modeling approach.
    Mehla K; Ramana J
    Biomed Pharmacother; 2017 Feb; 86():57-66. PubMed ID: 27939520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Software platforms to facilitate reconstructing genome-scale metabolic networks.
    Hamilton JJ; Reed JL
    Environ Microbiol; 2014 Jan; 16(1):49-59. PubMed ID: 24148076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
    Trawick JD; Schilling CH
    Biochem Pharmacol; 2006 Mar; 71(7):1026-35. PubMed ID: 16329998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolic network approach for the identification and prioritization of antimicrobial drug targets.
    Chavali AK; D'Auria KM; Hewlett EL; Pearson RD; Papin JA
    Trends Microbiol; 2012 Mar; 20(3):113-23. PubMed ID: 22300758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review.
    Chung WY; Zhu Y; Mahamad Maifiah MH; Shivashekaregowda NKH; Wong EH; Abdul Rahim N
    J Antibiot (Tokyo); 2021 Feb; 74(2):95-104. PubMed ID: 32901119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and applications of genome-scale metabolic models.
    Gu C; Kim GB; Kim WJ; Kim HU; Lee SY
    Genome Biol; 2019 Jun; 20(1):121. PubMed ID: 31196170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA.
    Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS
    Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes.
    Shahbaaz M; Bisetty K; Ahmad F; Hassan MI
    Curr Top Med Chem; 2016; 16(9):1040-69. PubMed ID: 26303422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genetic and chemical synthetic lethality as probes of complexity in bacterial cell systems.
    Klobucar K; Brown ED
    FEMS Microbiol Rev; 2018 Jan; 42(1):. PubMed ID: 29069427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets.
    Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y
    Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-scale metabolic models as platforms for strain design and biological discovery.
    Mienda BS
    J Biomol Struct Dyn; 2017 Jul; 35(9):1863-1873. PubMed ID: 27251747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets.
    Lee DS; Burd H; Liu J; Almaas E; Wiest O; Barabási AL; Oltvai ZN; Kapatral V
    J Bacteriol; 2009 Jun; 191(12):4015-24. PubMed ID: 19376871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.